Neurology
RSSArticles
-
Pharmacology Watch: Is This the End of the Road for Calcium Supplementation?
In this issue: Calcium supplementation in women; type 2 diabetes treatments and pancreatitis risk; treating chronic idiopathic urticaria; rivaroxaban and VTE; and FDA actions. -
Open-Lung Ventilation in ARDS is Not Necessarily Lung Protective
These two reports of large, multicenter, randomized, controlled trials of high-frequency oscillatory ventilation (HFOV) as compared to conventional lung-protective ventilation (LPV) in patients with the acute respiratory distress syndrome (ARDS) were electronically published on the same day in The New England Journal of Medicine. -
High-Flow Nasal Cannula — What Is it, How Does it Work, and Do We Know if it Works?
The use of high-flow nasal cannula (HFNC) systems for oxygen delivery in critical care has exploded over the past decade. -
Lowering Blood Pressure but Raising the Risk of Hip Fracture
The risk of hip fracture goes up for about 6 weeks immediately after older people start taking antihypertensives. -
Clinical Briefs in Primary Care Supplement
-
Tight vs Loose Rate Control in Permanent Atrial Fibrillation
The Rate Control Efficacy in Permanent Atrial Fibrillation (RACE II) trial compared strict rate control vs lenient rate control in patients with permanent atrial fibrillation. -
Stroke Alert: A Review of Current Clinical Stroke Literature
Mediterranean diet can reduce risk for stroke -
Carbapenem-Resistant Enterobacteriaceae an Increasing Threat in the United States
The frequency of isolation of carbapenem-resistant Enterobacteriaceae is increasing in the U.S., with the highest prevalence in the northeastern region. -
Hospital Medicine Alert - Full May 1, 2013 Issue in PDF
-
Pharmacology Watch: New Study on Chelation Therapy Proves Controversial
Chelation therapy for cardiovascular disease; statins and kidney injuries; chlorthalidone for hypertension; and FDA actions.